This contains promotional content developed under the direction of Gilead Sciences, Inc. and it is intended for healthcare professionals in the EU-EEA only.
Prescribing information for Veklury (remdesivir) can be found here. Adverse events should be reported to Gilead at [email protected].
This comprehensive webinar brings together infectious disease specialists Andrew Ustianowski and Jakob Malin to discuss the current state of COVID-19 management in hospital settings. COVID-19 is now endemic and many patients present with atypical disease manifestations.1 On the positive side, we have a better understanding of what constitutes appropriate care.
Topics covered:
- Current epidemiology and viral evolution – Why variants remain unpredictable and diagnosis challenges persist
- Changing patient presentations – Atypical symptoms in elderly patients with multiple comorbidities
- Test, assess, and treat strategies – Early diagnosis and maintaining clinical awareness
- Evidence-based treatment protocols – Antivirals, steroids, and immunomodulators across disease phases
- Real-world case management – COPD exacerbation triggered by COVID-19
Speakers:
Andrew Ustianowski1
Jakob Malin2
1. North Manchester General Hospital, UK
2. University Hospital of Cologne, Germany
GFM-VKY-0067 | January 2026
Reference:
1. Kagami K et al. Association between confirmed COVID-19 cases at hospitals and SARS-CoV-2 levels in municipal wastewater during the pandemic and endemic phases. Environ Int. 2025;197:109342.
